| Literature DB >> 29466424 |
Tassapol Singalavanija1, Somsanguan Ausayakhun1, Chulaluck Tangmonkongvoragul1.
Abstract
Human immunodeficiency virus (HIV) causes impairment to the human immune system which leads to immunocompromised conditions, including ocular complications. Several important HIV-associated disorders may involve the anterior segment, ocular surface, and adnexae organ such as dry eye, blepharitis which reduce quality of life of patients. In present, potent antiretroviral therapies HAART (highly active antiretroviral therapy) has improved the length and quality of life which may lead to an increased prevalence of anterior segment ocular disorders. Hence, this study has been undertaken to identify the prevalence and associated factors of anterior segment and external ocular disorder in HIV infected patients in the era of HAART. A prospective descriptive cross sectional study was carried out in HIV positive patients conducted at the Department of Ophthalmology, Chiang Mai University Hospital, from February 2014 to October 2015. Detail history and ocular examination was carried out to examine for anterior segment and external ocular disorders. A total number of 363 patients were included for this prospective cross-sectional study. From the total of 363 patients, 123 patients had an anterior segment and external ocular disorder which account as the prevalence of 33.9%. The most common anterior segment manifestations was dry eye seen in 36 patients (9.9%), followed by posterior blepharitis (Meibomian gland dysfunction) seen in 23 patients (6.3%) and anterior blepharitis seen in 12 patients (3.3%). Other ocular complications included microvasculopathy, immune recovery uveitis, conjunctivitis, papilloma, anterior uveitis, corneal ulcer, nevus, trichiasis, molluscum contangiosum, Kaposi sarcoma, interstitial keratitis, conjunctival lymphangiectasia, dacryocystitis, vernal keratoconjunctivitis and eyelid penicilosis. In this study, the prevalance of anterior segment disorders was higher than in the preHAART era. Dry eye, blepharitis and uveitis were the top three most common anterior segment disorders in the HAART era. The statistical analysis showed no association between age, sex, CD4 count, duration of infection or receiving HAART and anterior segment disorders. Anterior segment abnormalities reduce the quality of life of patients, so ophthalmologists have to be aware and complete ocular examination should be performed in all HIV infected patients.Entities:
Mesh:
Year: 2018 PMID: 29466424 PMCID: PMC5821368 DOI: 10.1371/journal.pone.0193161
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline demographic and laboratory characteristics of 363 HIV infected patients.
| Demographic data | Anterior segment manifestation | Non-Anterior segment manifestation | Total | P value | |||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| 59 | 16.3 | 115 | 31.7 | 174 | 47.9 | 0.993 | |
| 64 | 17.6 | 125 | 34.4 | 189 | 52.1 | ||
| 41.83 ± 10.76 | 44.17 ± 11.51 | 42.62 ± 11.06 | 0.056 | ||||
| Less than 10 | 1 | 0.3 | 0 | 0 | 1 | 0.3 | 0.335 |
| 10–19 | 0 | 0 | 6 | 1.6 | 6 | 1.6 | |
| 20–29 | 9 | 2.5 | 22 | 6.1 | 31 | 8.6 | |
| 30–39 | 36 | 9.9 | 66 | 18.2 | 102 | 28.2 | |
| 40–49 | 43 | 11.9 | 89 | 24.6 | 132 | 36.5 | |
| 50–59 | 19 | 5.2 | 43 | 11.9 | 62 | 17.1 | |
| 60 or more | 15 | 4.1 | 14 | 3.9 | 29 | 8.0 | |
| 343.08 ± 278 | 398.04 ± 298 | 361.86 ± 283 | 0.082 | ||||
| 5 (1–10) | 8 (2–12) | 5 (1–10) | 0.003 | ||||
| 119 | 32.8 | 234 | 64.5 | 353 | 97.2 | 0.739 | |
| 4 | 1.1 | 6 | 1.7 | 10 | 2.8 | ||
Prevalence and mean CD4 level of each types of anterior segment and external ocular disorders.
| Ocular disorder | CD4 T-cell level | Mean CD4 | Number of cases | Number of eyes | Overall prevalence | |
|---|---|---|---|---|---|---|
| ≤ 200 | >200 | |||||
| No ocular disorder | 88(24.4%) | 150 (41.6%) | 343.04 (±278.04) | 241 | 482 | 66.3% |
| Dry eye | 7 (1.9%) | 29 (8%) | 486.83 (±283.06) | 36 | 68 | 9.9% |
| Posterior blepharitis | 6 (1.7%) | 17 (4.7%) | 556.78 (±316.45) | 23 | 46 | 6.3% |
| Anterior blepharitis | 2 (0.6%) | 10 (2.8%) | 444.25 (±223.46) | 12 | 21 | 3.3% |
| Conjunctival microvasculopathy | 0 | 9 (2.5%) | 567.11 (±225.16) | 9 | 14 | 2.5% |
| Immune recovery uveitis | 5 (1.4%) | 4 (1.1%) | 117.89 (±101.57) | 9 | 15 | 2.5% |
| Conjunctivitis | 3 (0.8%) | 3 (0.8%) | 356.50 (±262.68) | 6 | 11 | 1.7% |
| Papilloma | 1 (0.3%) | 5 (1.4%) | 522.50 (±273.48) | 6 | 7 | 1.7% |
| Anterior uveitis | 3 (0.9%) | 1 (0.3%) | 109.50 (±117.72) | 4 | 6 | 1.1% |
| Corneal ulcer | 1 (0.3%) | 3 (0.8%) | 439.25 (±276.55) | 4 | 4 | 1.1% |
| Nevus | 1 (0.3%) | 2 (0.6%) | 451.00 (±371.58) | 3 | 4 | 0.8% |
| Trichiasis | 0 | 2 (0.6%) | 810.00 (±475.18) | 2 | 3 | 0.6% |
| Molluscum contangiosum | 2 (0.6%) | 0 | 63.50 (±51.61) | 2 | 2 | 0.6% |
| Kaposi sarcoma | 1 (0.3%) | 0 | 19 | 1 | 1 | 0.3% |
| Interstitial keratitis | 0 | 1 (0.3%) | 432 | 1 | 1 | 0.3% |
| Conjunctival lymphangiectasia | 0 | 1 (0.3%) | 288 | 1 | 1 | 0.3% |
| Dacryocystitis | 0 | 1 (0.3%) | 235 | 1 | 1 | 0.3% |
| Vernal keratoconjunctivitis | 1 (0.3%) | 0 | 17 | 1 | 2 | 0.3% |
| Eyelid penicilosis | 0 | 0 | 7 | 1 | 2 | 0.3% |
Fig 1Severe dry eye with lipid deposit.
Fig 2Papilloma.
Fig 3Severe corneal ulcer with perforation.
Fig 4Severe molluscum contagiosum.
Fig 5Severe molluscum contagiosum.
Fig 6Kaposi sarcoma.
Fig 7Kaposi sarcoma.
Multivariate analysis of associated factors for the anterior segment and external ocular disorders in human immunodeficiency virus-infected patients.
| Associated factor | Ocular manifestation (%) | Unadjusted OR | Adjusted OR | P-value | ||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | |||||||
| N | % | N | % | |||||
| Sex | Male | 59 | 16.3 | 115 | 31.7 | 0.998 | 0.935 | 0.772 |
| Age (yr) | ≤ 40 | 55 | 14.9 | 104 | 28.7 | 1.016 | 1.202 | 0.446 |
| CD4+ count | < 200 | 44 | 11.6 | 88 | 24.4 | 0.884 | 1.035 | 0.899 |
| HAART | Yes | 119 | 32.8 | 234 | 64.5 | 1.311 | 1.616 | 0.482 |
| Duration of infection (yr) | < 5 | 44 | 35.8 | 119 | 49.6 | 1.766 | 1.916 | 0.062 |
Values are presented as number (%); Adjusted for sex, age, CD4+ count, HAART and duration of infection.
OR = odds ratio; CI = confidence interval; HAART = highly active antiretroviral therapy
§; adjusted for age, CD4+ cell count, HAART and duration of infection
ɸ; adjusted for sex, CD4+ cell count, HAART and duration of infection
ʈ; adjusted for age, sex, HAART and duration of infection
‡; adjusted for age, sex, CD4+ cells count and duration of infection
α; adjusted for age, sex, CD4+ cells count and HAART